Back

Left ventricular ejection fraction and clinical outcomes after transcatheter aortic valve implantation

1 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Advancing valvular heart disease evaluation: the role of imaging Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Anne Wang Gottlieb

Karolinska University Hospital, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Differentiation of severe from non-severe mitral stenosis with dimensionless index and its prognostic implications in patients with rheumatic mitral stenosis
Doctor M. Chan (Selangor, MY)
Abstract Slides Video
Presentation thumbnail
Aortic valve tissue quantification in bicuspid aortic valve stenosis
Doctor Z. Ye (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Efficacy of native T1 mapping for patients with non-ischemic cardiomyopathy and ventricular functional mitral regurgitation undergoing transcatheter edge-to-edge repair
Doctor H. Tsunamoto (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Good agreement between cardiac magnetic imaging protocols using free-breathing and breath-holding techniques for flow quantification in valvular heart disease
Doctor S. Gao (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
True-MAD and pseudo-MAD in consecutive patients undergoing cardiovascular magnetic resonance
Doctor K. Stankowski (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Advancing valvular heart disease evaluation: the role of imaging

The Event

Event poster

ESC Congress 2024

1 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Left ventricular ejection fraction improvement after transcatheter aortic valve replacement: predictors and prognosis
thumbnail
Congress Presentation
Unlocking recovery: predictors and outcomes of left ventricular dysfunction after TAVI
thumbnail
Congress Presentation
Prognostic significance of left ventricular ejection fraction in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources